(Total Views: 813)
Posted On: 07/27/2025 8:33:43 PM
Post# of 155727
Reason for S3's is being overlooked --- they're regulatory pre-approved shares so you can move with speed in the future.
There is no type of issuance deal justified @ a market discount to this .30 level with what is being waited on. Cytodyn is still moving frwd on money in the bank.
If/when the sp rightfully reacts to good news, the aquirer knows the shares offered are approved.
The S3 also reminds of the CFO employment agreement
The public/private tasks he agreed to perform as needed
Have never seen a company issue their entire Shelf in 1 offering.
It's why they have future expiration dates --- spread out the Offering(s) over time as you develop
Have never seen a company issue their entire Shelf in 1 offering.
It's why they have future expiration dates --- spread out the Offering(s) over time as you develop
July 24th, 2025:
https://stocktwits.com/my69z/message/622324975
Whatever the type of aquirer.
$100m cap says solo for now.
There is no type of issuance deal justified @ a market discount to this .30 level with what is being waited on. Cytodyn is still moving frwd on money in the bank.
If/when the sp rightfully reacts to good news, the aquirer knows the shares offered are approved.
The S3 also reminds of the CFO employment agreement
The public/private tasks he agreed to perform as needed
Have never seen a company issue their entire Shelf in 1 offering.
It's why they have future expiration dates --- spread out the Offering(s) over time as you develop
Have never seen a company issue their entire Shelf in 1 offering.
It's why they have future expiration dates --- spread out the Offering(s) over time as you develop
July 24th, 2025:
https://stocktwits.com/my69z/message/622324975
Whatever the type of aquirer.
$100m cap says solo for now.
(5)
(0)
